Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Some common medications can harm male fertility, but many effects can be reversed.

New treatments for male hypogonadism are effective and should be personalized.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

The normal human prostate does not significantly affect blood DHT levels.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Regulating certain sex hormones may help delay facial aging.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Clomiphene citrate improves fertility in men taking finasteride for hair loss.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.